ro 31-8425 has been researched along with angiotensin ii in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, S; Barnes, WG; Lefkowitz, RJ; Wei, H | 1 |
Bardin, S; Billet, S; Clauser, E; Conchon, S; Tacine, R | 1 |
2 other study(ies) available for ro 31-8425 and angiotensin ii
Article | Year |
---|---|
Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Arrestins; beta-Arrestin 2; beta-Arrestins; Cell Line; DNA-Binding Proteins; Early Growth Response Protein 1; Enzyme Activation; GTP-Binding Proteins; Humans; Immediate-Early Proteins; Indoles; Maleimides; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Molecular Sequence Data; Mutagenesis, Site-Directed; Protein Binding; Protein Kinase C; Receptor, Angiotensin, Type 1; Recombinant Fusion Proteins; RNA, Small Interfering; Second Messenger Systems; Sequence Alignment; Transcription Factors | 2004 |
The AT1A receptor "gain-of-function" mutant N111S/delta329 is both constitutively active and hyperreactive to angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Arrestins; beta-Arrestin 2; beta-Arrestins; Cell Line; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Imidazoles; Indoles; Inositol Phosphates; Maleimides; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Phosphorylation; Protein Binding; Pyridines; Receptor, Angiotensin, Type 1; Transfection | 2006 |